Diminished matrix metalloproteinase 9 secretion in human immunodeficiency virus-infected mononuclear phagocytes: modulation of innate immunity and implications for neurological disease

J Neuroimmunol. 2004 Dec;157(1-2):11-6. doi: 10.1016/j.jneuroim.2004.08.033.

Abstract

Neurotoxic secretory products from virus-infected mononuclear phagocytes (MP; perivascular macrophages and microglia) orchestrate the neuropathogenesis of human immunodeficiency virus type one (HIV-1) infection. To uncover such MP products and their relationship to disease, we used a proteomics platform consisting of one dimensional polyacrylamide gel electrophoresis (1-DE), mass spectrometry peptide sequencing, and bioinformatics in order to identify from HIV-1-infected monocyte-derived macrophages (MDM) secretions. Matrix metalloproteinase 9 (MMP 9) secreted in abundance in MDM was markedly down-regulated following viral infection. A negative correlation between MMP 9 and HIV-1 reverse transcriptase activity was shown by quantitative Western blot assays. These data further demonstrate immunoregulatory activities of HIV-1-infected MDM providing unique insights into cellular function in disease.

Publication types

  • Comparative Study
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Blotting, Western / methods
  • Computational Biology / methods
  • Electrophoresis, Polyacrylamide Gel / methods
  • HIV Reverse Transcriptase / metabolism
  • HIV-1 / physiology*
  • Humans
  • Mass Spectrometry / methods
  • Matrix Metalloproteinase 9 / analysis
  • Matrix Metalloproteinase 9 / metabolism*
  • Phagocytes / enzymology
  • Phagocytes / metabolism
  • Phagocytes / virology*
  • Sequence Analysis, Protein / methods
  • Time Factors

Substances

  • HIV Reverse Transcriptase
  • Matrix Metalloproteinase 9